844 related articles for article (PubMed ID: 15580261)
1. Genetically modified Plasmodium parasites as a protective experimental malaria vaccine.
Mueller AK; Labaied M; Kappe SH; Matuschewski K
Nature; 2005 Jan; 433(7022):164-7. PubMed ID: 15580261
[TBL] [Abstract][Full Text] [Related]
2. Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells.
Tarun AS; Dumpit RF; Camargo N; Labaied M; Liu P; Takagi A; Wang R; Kappe SH
J Infect Dis; 2007 Aug; 196(4):608-16. PubMed ID: 17624848
[TBL] [Abstract][Full Text] [Related]
3. Comparative efficacy of pre-erythrocytic whole organism vaccine strategies against the malaria parasite.
Friesen J; Matuschewski K
Vaccine; 2011 Sep; 29(40):7002-8. PubMed ID: 21787828
[TBL] [Abstract][Full Text] [Related]
4. Genetically attenuated Plasmodium berghei liver stages persist and elicit sterile protection primarily via CD8 T cells.
Mueller AK; Deckert M; Heiss K; Goetz K; Matuschewski K; Schlüter D
Am J Pathol; 2007 Jul; 171(1):107-15. PubMed ID: 17591958
[TBL] [Abstract][Full Text] [Related]
5. Medicine: knockout malaria vaccine?
Ménard R
Nature; 2005 Jan; 433(7022):113-4. PubMed ID: 15650722
[No Abstract] [Full Text] [Related]
6. A new approach to generate a safe double-attenuated Plasmodium liver stage vaccine.
Nagel A; Prado M; Heitmann A; Tartz S; Jacobs T; Deschermeier C; Helm S; Stanway R; Heussler V
Int J Parasitol; 2013 May; 43(6):503-14. PubMed ID: 23500072
[TBL] [Abstract][Full Text] [Related]
7. Arrest in the liver--a genetically defined malaria vaccine?
Frevert U; Nardin E
N Engl J Med; 2005 Apr; 352(15):1600-2. PubMed ID: 15829544
[No Abstract] [Full Text] [Related]
8. Genetically modified Plasmodium highlights the potential of whole parasite vaccine strategies.
Good MF
Trends Immunol; 2005 Jun; 26(6):295-7. PubMed ID: 15922944
[TBL] [Abstract][Full Text] [Related]
9. Plasmodium berghei: production and quantitation of hepatic stages derived from irradiated sporozoites in rats and mice.
Scheller LF; Stump KC; Azad AF
J Parasitol; 1995 Feb; 81(1):58-62. PubMed ID: 7876979
[TBL] [Abstract][Full Text] [Related]
10. Genetically attenuated parasite vaccines induce contact-dependent CD8+ T cell killing of Plasmodium yoelii liver stage-infected hepatocytes.
Trimnell A; Takagi A; Gupta M; Richie TL; Kappe SH; Wang R
J Immunol; 2009 Nov; 183(9):5870-8. PubMed ID: 19812194
[TBL] [Abstract][Full Text] [Related]
11. Assessing the adequacy of attenuation of genetically modified malaria parasite vaccine candidates.
Annoura T; Ploemen IH; van Schaijk BC; Sajid M; Vos MW; van Gemert GJ; Chevalley-Maurel S; Franke-Fayard BM; Hermsen CC; Gego A; Franetich JF; Mazier D; Hoffman SL; Janse CJ; Sauerwein RW; Khan SM
Vaccine; 2012 Mar; 30(16):2662-70. PubMed ID: 22342550
[TBL] [Abstract][Full Text] [Related]
12. Subpatent infection with nucleoside transporter 1-deficient Plasmodium blood stage parasites confers sterile protection against lethal malaria in mice.
Aly AS; Downie MJ; Mamoun CB; Kappe SH
Cell Microbiol; 2010 Jul; 12(7):930-8. PubMed ID: 20088947
[TBL] [Abstract][Full Text] [Related]
13. Reduced Plasmodium berghei sporozoite liver load associates with low protective efficacy after intradermal immunization.
Nganou-Makamdop K; Ploemen I; Behet M; Van Gemert GJ; Hermsen C; Roestenberg M; Sauerwein RW
Parasite Immunol; 2012 Dec; 34(12):562-9. PubMed ID: 23171040
[TBL] [Abstract][Full Text] [Related]
14. Genetically attenuated P36p-deficient Plasmodium berghei sporozoites confer long-lasting and partial cross-species protection.
Douradinha B; van Dijk MR; Ataide R; van Gemert GJ; Thompson J; Franetich JF; Mazier D; Luty AJ; Sauerwein R; Janse CJ; Waters AP; Mota MM
Int J Parasitol; 2007 Nov; 37(13):1511-9. PubMed ID: 17604034
[TBL] [Abstract][Full Text] [Related]
15. IL-12p40-independent induction of protective immunity upon multiple Plasmodium berghei irradiated sporozoite immunizations.
Romero JF; Ibrahim GH; Renggli J; Himmelrich H; Graber P; Corradin G
Parasite Immunol; 2007 Nov; 29(11):541-8. PubMed ID: 17944743
[TBL] [Abstract][Full Text] [Related]
16. Depletion of the Plasmodium berghei thrombospondin-related sporozoite protein reveals a role in host cell entry by sporozoites.
Labaied M; Camargo N; Kappe SH
Mol Biochem Parasitol; 2007 Jun; 153(2):158-66. PubMed ID: 17418435
[TBL] [Abstract][Full Text] [Related]
17. Genetically attenuated Plasmodium berghei liver stages induce sterile protracted protection that is mediated by major histocompatibility complex Class I-dependent interferon-gamma-producing CD8+ T cells.
Jobe O; Lumsden J; Mueller AK; Williams J; Silva-Rivera H; Kappe SH; Schwenk RJ; Matuschewski K; Krzych U
J Infect Dis; 2007 Aug; 196(4):599-607. PubMed ID: 17624847
[TBL] [Abstract][Full Text] [Related]
18. The whole parasite, pre-erythrocytic stage approach to malaria vaccine development: a review.
Epstein JE; Richie TL
Curr Opin Infect Dis; 2013 Oct; 26(5):420-8. PubMed ID: 23982233
[TBL] [Abstract][Full Text] [Related]
19. Protective efficacy and safety of liver stage attenuated malaria parasites.
Kumar H; Sattler JM; Singer M; Heiss K; Reinig M; Hammerschmidt-Kamper C; Heussler V; Mueller AK; Frischknecht F
Sci Rep; 2016 May; 6():26824. PubMed ID: 27241521
[TBL] [Abstract][Full Text] [Related]
20. Cellular and humoral immune effector mechanisms required for sterile protection against sporozoite challenge induced with the novel malaria vaccine candidate CelTOS.
Bergmann-Leitner ES; Legler PM; Savranskaya T; Ockenhouse CF; Angov E
Vaccine; 2011 Aug; 29(35):5940-9. PubMed ID: 21722682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]